Emergency contraception in the iPLEDGE program : A cross-sectional survey of pediatric dermatology provider understanding and practice
© 2022 Wiley Periodicals LLC..
For patients with acne treated with the teratogen isotretinoin, emergency contraception (EC) is the only recourse when abstinence fails or effective contraception is not properly used. The purpose of this study was to evaluate the current understanding and provision of EC among pediatric dermatology providers. The survey found that 37% (21/57) of providers indicated they were at least somewhat confident in their understanding of EC. 7% (4/57) of providers agreed/strongly agreed that they provided EC counseling to all patients of reproductive potential at their initial visit and 3.5% (2/57) agreed/strongly agreed that they provide EC counseling at follow-up visits. Our survey results suggest the need for improved EC education for pediatric dermatology providers and subsequent counseling for patients of reproductive potential on isotretinoin therapy.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:39 |
|---|---|
| Enthalten in: |
Pediatric dermatology - 39(2022), 5 vom: 01. Sept., Seite 727-730 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Smiley, Catherine E [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Accutane |
|---|
| Anmerkungen: |
Date Completed 11.10.2022 Date Revised 11.10.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/pde.15086 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM344379000 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM344379000 | ||
| 003 | DE-627 | ||
| 005 | 20231226022632.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/pde.15086 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1147.xml |
| 035 | |a (DE-627)NLM344379000 | ||
| 035 | |a (NLM)35918308 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Smiley, Catherine E |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Emergency contraception in the iPLEDGE program |b A cross-sectional survey of pediatric dermatology provider understanding and practice |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.10.2022 | ||
| 500 | |a Date Revised 11.10.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022 Wiley Periodicals LLC. | ||
| 520 | |a For patients with acne treated with the teratogen isotretinoin, emergency contraception (EC) is the only recourse when abstinence fails or effective contraception is not properly used. The purpose of this study was to evaluate the current understanding and provision of EC among pediatric dermatology providers. The survey found that 37% (21/57) of providers indicated they were at least somewhat confident in their understanding of EC. 7% (4/57) of providers agreed/strongly agreed that they provided EC counseling to all patients of reproductive potential at their initial visit and 3.5% (2/57) agreed/strongly agreed that they provide EC counseling at follow-up visits. Our survey results suggest the need for improved EC education for pediatric dermatology providers and subsequent counseling for patients of reproductive potential on isotretinoin therapy | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a REMS | |
| 650 | 4 | |a accutane | |
| 650 | 4 | |a contraception | |
| 650 | 4 | |a emergency contraception | |
| 650 | 4 | |a iPLEDGE | |
| 650 | 4 | |a isotretinoin | |
| 650 | 7 | |a Teratogens |2 NLM | |
| 650 | 7 | |a Isotretinoin |2 NLM | |
| 650 | 7 | |a EH28UP18IF |2 NLM | |
| 700 | 1 | |a Butt, Melissa |e verfasserin |4 aut | |
| 700 | 1 | |a Zaenglein, Andrea L |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pediatric dermatology |d 1986 |g 39(2022), 5 vom: 01. Sept., Seite 727-730 |w (DE-627)NLM012965154 |x 1525-1470 |7 nnns |
| 773 | 1 | 8 | |g volume:39 |g year:2022 |g number:5 |g day:01 |g month:09 |g pages:727-730 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/pde.15086 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 39 |j 2022 |e 5 |b 01 |c 09 |h 727-730 | ||